# Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates

> **NCT00031460** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 46 (actual)

## Conditions studied

- Herpes Simplex

## Interventions

- **DRUG:** Acyclovir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00031460
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-12
- **Primary completion:** 2008-02
- **Final completion:** 2008-04
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031460, "Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00031460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*